Accepted for Publication: March 28, 2011.
Author Contributions: Drs Passeron and Ortonne had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Passeron, Fontas, Lacour, and Ortonne. Acquisition of data: Passeron and Kang. Analysis and interpretation of data: Passeron, Fontas, Bahadoran, Lacour, and Ortonne. Drafting of the manuscript: Passeron, Fontas, and Ortonne. Critical revision of the manuscript for important intellectual content: Passeron, Fontas, Kang, Bahadoran, Lacour, and Ortonne. Statistical analysis: Fontas. Obtained funding: Passeron and Ortonne. Administrative, technical, and material support: Lacour and Ortonne. Study supervision: Passeron.
Financial Disclosure: Galderma provided the TCC used in the study.
Funding/Support: This study was supported by the Nice University Hospital (CHU Nice) and the Association Ni çoise pour l ’Etude de la Dermatologie (ANED).
Role of the Sponsors: The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; or in the preparation, review, or approval of the manuscript.
Trial Registration: clinicaltrials.gov Identifier: NCT00863178
Previous Presentation: This research was presented at the 18th Congress of the European Academy of Dermatology and Venereology; October 2009; Berlin, Germany.
Additional Contributions: Charlotte Sakarowitch, provided valuable help in the statistical analysis review.